Levetiracetam Viatris

Levetiracetam, the active ingredient in Levetiracetam Viatris, is an antiepileptic presented as a tablet for oral use. It is indicated for the treatment of various seizure types in adults and children. The medication works by modulating neuronal excitability and is prescribed by healthcare professionals for seizure management.

GNH USA supplies Levetiracetam Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable access across European and global markets.

Levetiracetam is an antiepileptic medication that targets abnormal neuronal firing and is employed in the management of several seizure disorders.

- Partial seizures: reduces the frequency of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: decreases the occurrence of sudden muscle jerks.

Levetiracetam may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Fatigue: feeling of tiredness or lack of energy. - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate cranial pain. - Somnolence: increased sleepiness during the day. - Irritability: mood changes leading to agitation. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Severe allergic reactions: including rash, Stevens‑Johnson syndrome, or anaphylaxis. - Mood disorders: depression, suicidal thoughts, or aggressive behavior. - Blood disorders: leukopenia, thrombocytopenia, or anemia. - Multi‑organ involvement: rare cases of hepatic or renal dysfunction. - Severe skin reactions: toxic epidermal necrolysis. - Respiratory depression: in combination with other CNS depressants.

When prescribing or dispensing levetiracetam, several safety considerations should be observed.

- Dose adjustment in renal impairment: reduce the dose according to the patient’s creatinine clearance. - Monitor psychiatric symptoms: watch for mood changes, depression, or suicidal ideation. - Avoid abrupt discontinuation: taper the medication under medical supervision to prevent seizure recurrence. - Use caution in elderly patients: increased sensitivity to central nervous system effects may occur. - Store below 25°C: keep in the original packaging, protect from moisture.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Concomitant use with carbamazepine: may lower levetiracetam plasma concentrations. - Co‑administration with enzyme‑inducing antiepileptics (phenytoin, phenobarbital): may reduce therapeutic effect. - Combination with strong CYP inhibitors (ketoconazole, itraconazole): potential increase in levetiracetam levels.

Moderate Interactions (Monitor Closely): - Concurrent use with antidepressants (SSRIs, SNRIs): monitor for behavioral changes. - Use with other CNS depressants (benzodiazepines, alcohol): may enhance sedation or dizziness. - Interaction with renal‑excreted drugs (e.g., NSAIDs): monitor renal function and adjust dosing if needed.